TOP NEWS

PhageTech Finds $2.4M For Biosensors For Disease Detection

Irvine-based PhageTech, a developer of disease detection sensors, said late Monday morning that it has raised $2.4M in a funding round. The Series A funding came from Mark IV Capital and Black River Investments. According to PhageTech it is developing biosensor technology which enables early detection of cancer and other diseases, using a one minute blood and urine test. PhageTech is led by Richard Henson. The company said the funds will go towards completing development and FDA clearance of its technology.


LATEST HEADLINES

More Headlines

BROWSE ISSUES